Key Takeaways On Feb. 6, 2026, FDA announced that it would take action to restrict access to GLP-1 ingredients for non-FDA ...

A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.

Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from top U.S. health officials at the FDA and ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...

FDA Moves to Restrict Compounding GLP-1 Ingredients ...

OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. | The complaint ...

Compounding pharmacies are facilities that are able to make customized medications. This could be to alter a drug's dosage or composition for medical purposes. Many patients have benefitted from drug ...

BOSTONMassachusetts shut down another compounding pharmacy over sterility concerns after a surprise inspection prompted by the nationwide meningitis outbreak linked to a different company, state ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (StatePoint) Most consumers know how a traditional pharmacy works ...